Ravandi, F., Yi, C. A., Cortes, J. E., Levis, M., Faderl, S., Garcia-Manero, G., . . . Kantarjian, H. (2014). Final Report of Phase II Study of Sorafenib, Cytarabine, and Idarubicin for Initial Therapy in Younger Patients with Acute Myeloid Leukemia.
Stile di citazione ChicagoRavandi, Farhad, et al. Final Report of Phase II Study of Sorafenib, Cytarabine, and Idarubicin for Initial Therapy in Younger Patients With Acute Myeloid Leukemia. 2014.
Citazione MLARavandi, Farhad, et al. Final Report of Phase II Study of Sorafenib, Cytarabine, and Idarubicin for Initial Therapy in Younger Patients With Acute Myeloid Leukemia. 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.